{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:02:57Z","timestamp":1788390177765,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.fertnstert.2022.01.027","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:17:17Z","timestamp":1646414237000},"page":"669-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Stimulation for low responder patients: adjuvants during stimulation"],"prefix":"10.1016","volume":"117","author":[{"given":"Roger J.","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2022.01.027_bib1","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/humrep\/deab098","article-title":"How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients","volume":"36","author":"Lensen","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ajo.13321","article-title":"IVF add-ons in Australia and New Zealand: a systematic assessment of IVF clinic websites","volume":"61","author":"Lensen","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib3","author":"Scott"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.rbmo.2019.02.003","article-title":"Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate","volume":"38","author":"Norman","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2265.1988.tb00252.x","article-title":"Growth hormone facilitates ovulation induction by gonadotrophins","volume":"29","author":"Homburg","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in\u00a0vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0015-0282(16)56825-3","article-title":"Adjuvant growth hormone treatment during in\u00a0vitro fertilization: a randomized, placebo-controlled study","volume":"62","author":"Bergh","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response","volume":"131","author":"Bayoumi","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/humrep\/10.1.40","article-title":"Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study","volume":"10","author":"Dor","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib12","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/humrep\/14.8.1939","article-title":"Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?","volume":"14","author":"Howles","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a\u00a0GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fendo.2019.00500","article-title":"Use of growth hormone in the IVF treatment of women with poor ovarian reserve","volume":"10","author":"Hart","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","article-title":"The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials","volume":"18","author":"Yang","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.fertnstert.2020.03.007","article-title":"Growth hormone cotreatment for poor responders undergoing in\u00a0vitro fertilization cycles: a systematic review and meta-analysis","volume":"114","author":"Cozzolino","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tjog.2020.10.003","article-title":"Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders; randomized controlled trial","volume":"60","author":"Mohammad","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0015-0282(16)54724-4","article-title":"Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in\u00a0vitro fertilization: a randomized, double-blind, placebo-control trial","volume":"56","author":"Owen","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0015-0282(16)58217-X","article-title":"Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology","volume":"65","author":"Suikkari","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0015-0282(16)55266-2","article-title":"The effect of growth hormone supplementation on in\u00a0vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study","volume":"58","author":"Younis","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60011-9","article-title":"Effect of growth hormone on oocyte competence in patients with multiple IVF failures","volume":"18","author":"Hazout","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/humupd\/dmp026","article-title":"Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis","volume":"15","author":"Kolibianakis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","article-title":"How to improve the probability of pregnancy in poor responders undergoing in\u00a0vitro fertilization: a systematic review and meta-analysis","volume":"91","author":"Kyrou","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000099.pub3","article-title":"Growth hormone for in\u00a0vitro fertilization","author":"Duffy","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib25","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0002-9343(99)80060-6","article-title":"Insulin-like growth factors: clinical experience in ovarian function","volume":"98","author":"Buyalos","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/HUMREP\/10.6.1341","article-title":"In-vivo studies on ovarian insulin-like growth factor I concentrations in human preovulatory follicles and human ovarian circulation","volume":"10","author":"Pellegrini","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1098-2795(199908)53:4<398::AID-MRD5>3.0.CO;2-I","article-title":"Messenger RNA expression and protein localization of growth hormone in bovine ovarian tissue and in cumulus oocyte complexes (COCs) during in\u00a0vitro maturation","volume":"53","author":"Izadyar","year":"1999","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/endo.135.5.7525255","article-title":"Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I","volume":"135","author":"Chun","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/mend.11.13.0032","article-title":"Insulin-like growth factor I regulates gonadotropin responsiveness in the murine ovary","volume":"11","author":"Zhou","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10815-005-9014-0","article-title":"Pregnancy and delivery after in\u00a0vitro maturation of naked ICSI-GV oocytes with GH and transfer of a frozen thawed blastocyst: case report","volume":"23","author":"Menezo","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/humrep\/17.4.1017","article-title":"Follicular fluid markers of oocyte developmental potential","volume":"17","author":"Mendoza","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12884-020-03004-9","article-title":"Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial","volume":"20","author":"Li","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib33","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/GCO.0000000000000360","article-title":"Growth hormone in IVF cycles: any hope?","volume":"29","author":"Hart","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib35","doi-asserted-by":"crossref","first-page":"e6443","DOI":"10.1097\/MD.0000000000006443","article-title":"The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0974-1208.183515","article-title":"Effective treatment protocol for poor ovarian response: a systematic review and meta-analysis","volume":"9","author":"Jeve","year":"2016","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/humupd\/dmz046","article-title":"Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis","volume":"26","author":"Zhang","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib38","first-page":"798","article-title":"[Effects of co-administration of growth hormone(GH) and aspirin to women during in\u00a0vitro fertilization and embryo transfer (IVF-ET) cycles]","volume":"13","author":"Guan","year":"2007","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib39","article-title":"[The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in\u00a0vitro fertilization and embryo transfer]","volume":"29","author":"Zhuang","year":"1994","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2022.01.027_bib40","first-page":"i37","article-title":"A randomised double blind placebo controlled study of recombinant human growth hormone (h-GH) on live birth rates in women who are poor responders","volume":"31","author":"Norman","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0015-0282(16)45731-6","article-title":"Ultrasound control of clomiphene\/human chorionic gonadotropin stimulated cycles for oocyte recovery and in\u00a0vitro fertilization","volume":"36","author":"Hoult","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1026280508821","article-title":"Treatment-associated serum FSH levels in very poor responders to ovarian stimulation","volume":"20","author":"Saadat","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/humrep\/deaa336","article-title":"Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders","volume":"36","author":"Moffat","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/uog.17442","article-title":"Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis","volume":"50","author":"Bechtejew","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib45","article-title":"Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in\u00a0vitro fertilisation","volume":"11","author":"Kamath","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009749.pub2","article-title":"Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction","author":"Nagels","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humrep\/deab249","article-title":"Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial","volume":"37","author":"B\u00fclow","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib48","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/09513590.2014.920002","article-title":"Comparison of estradiol and progesterone priming\/antagonist\/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection","volume":"30","author":"Yucel","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib51","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00404-016-4164-0","article-title":"A comparison among different methods of letrozole combined with gonadotropin in an antagonist protocol and high-dose gonadotropin ovarian stimulation antagonist protocol in poor ovarian responders undergoing in\u00a0vitro fertilization","volume":"294","author":"Yang","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib52","first-page":"101","article-title":"Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: an RCT","volume":"15","author":"Ebrahimi","year":"2017","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib53","first-page":"653","article-title":"Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial","volume":"17","author":"Moini","year":"2019","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-020-00666-z","article-title":"Does daily coadministration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?","volume":"13","author":"Shapira","year":"2020","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000513669","article-title":"A novel stimulation protocol for poor-responder patients: combining the stop GnRH-ag protocol with letrozole priming and multiple-dose GnRH-ant: a proof of concept","volume":"86","author":"Orvieto","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa066","article-title":"Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis","volume":"2021","author":"Montoya-Botero","year":"2021","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102139","article-title":"Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: a meta-analysis","volume":"50","author":"Qin","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.fertnstert.2018.03.019","article-title":"Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline","volume":"109","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib60","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(dagger)","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib61","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","article-title":"Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study","volume":"20","author":"Safdarian","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.fertnstert.2022.01.027_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in\u00a0vitro fertilization: randomized control trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:32:27Z","timestamp":1758011547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028222000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0015028222000620"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.01.027","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulation for low responder patients: adjuvants during stimulation","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92022 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}